-
1
-
-
84924271853
-
Global cancer statistics, 2012
-
Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J Clin 65, 87-108 (2015).
-
(2015)
CA Cancer J Clin
, vol.65
, pp. 87-108
-
-
Torre, L.A.1
-
2
-
-
12644292106
-
The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma an attempt at a histo-clinical classification
-
Lauren, P. The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. An Attempt at a Histo-Clinical Classification. Acta Pathol Microbiol Scand 64, 31-49 (1965).
-
(1965)
Acta Pathol Microbiol Scand
, vol.64
, pp. 31-49
-
-
Lauren, P.1
-
3
-
-
84891738417
-
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: An international pooled analysis
-
Camargo, M. C. et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut 63, 236-243 (2014).
-
(2014)
Gut
, vol.63
, pp. 236-243
-
-
Camargo, M.C.1
-
4
-
-
77952903266
-
Helicobacter pylori: Gastric cancer and beyond
-
Polk, D. B., Peek, R. M., Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 10, 403-414 (2010).
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 403-414
-
-
Polk, D.B.1
Peek, R.M.2
-
5
-
-
0028789305
-
Helicobacter pylori and atrophic gastritis: Importance of the cagA status
-
Kuipers, E. J., Perez-Perez, G. I., Meuwissen, S. G., Blaser, M. J. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 87, 1777-1780 (1995).
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 1777-1780
-
-
Kuipers, E.J.1
Perez-Perez, G.I.2
Meuwissen, S.G.3
Blaser, M.J.4
-
6
-
-
0029043658
-
Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach
-
Blaser, M. J. et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55, 2111-2115 (1995).
-
(1995)
Cancer Res
, vol.55
, pp. 2111-2115
-
-
Blaser, M.J.1
-
7
-
-
0030975595
-
Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection
-
Parsonnet, J., Friedman, G. D., Orentreich, N., Vogelman, H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40, 297-301 (1997).
-
(1997)
Gut
, vol.40
, pp. 297-301
-
-
Parsonnet, J.1
Friedman, G.D.2
Orentreich, N.3
Vogelman, H.4
-
8
-
-
58349115660
-
Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo
-
Bronte-Tinkew, D. M. et al. Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res 69, 632-639 (2009).
-
(2009)
Cancer Res
, vol.69
, pp. 632-639
-
-
Bronte-Tinkew, D.M.1
-
9
-
-
77952410241
-
Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells
-
Lee, I. O. et al. Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells. J Biol Chem 285, 16042-16050 (2010).
-
(2010)
J Biol Chem
, vol.285
, pp. 16042-16050
-
-
Lee, I.O.1
-
10
-
-
0037169076
-
SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein
-
Higashi, H. et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295, 683-686 (2002).
-
(2002)
Science
, vol.295
, pp. 683-686
-
-
Higashi, H.1
-
11
-
-
17344379177
-
Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion
-
Odenbreit, S. et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287, 1497-1500 (2000).
-
(2000)
Science
, vol.287
, pp. 1497-1500
-
-
Odenbreit, S.1
-
12
-
-
0029891126
-
Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa
-
Yamaoka, Y., Kita, M., Kodama, T., Sawai, N., Imanishi, J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 110, 1744-1752 (1996).
-
(1996)
Gastroenterology
, vol.110
, pp. 1744-1752
-
-
Yamaoka, Y.1
Kita, M.2
Kodama, T.3
Sawai, N.4
Imanishi, J.5
-
13
-
-
0034952052
-
Relation between cytokines and Helicobacter pylori in gastric cancer
-
Yamaoka, Y. et al. Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter 6, 116-124 (2001).
-
(2001)
Helicobacter
, vol.6
, pp. 116-124
-
-
Yamaoka, Y.1
-
14
-
-
0034599429
-
Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells
-
Schneider, M. R. et al. Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer letters 151, 31-38 (2000).
-
(2000)
Cancer Letters
, vol.151
, pp. 31-38
-
-
Schneider, M.R.1
-
15
-
-
0030061195
-
Serum interleukin-6 levels reflect disease status of gastric cancer
-
Wu, C. W. et al. Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 91, 1417-1422 (1996).
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 1417-1422
-
-
Wu, C.W.1
-
16
-
-
0029165742
-
Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma
-
Kabir, S., Daar, G. A. Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma. Cancer letters 95, 207-212 (1995).
-
(1995)
Cancer Letters
, vol.95
, pp. 207-212
-
-
Kabir, S.1
Daar, G.A.2
-
17
-
-
23844445451
-
Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling
-
Jenkins, B. J. et al. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat Med 11, 845-852 (2005).
-
(2005)
Nat Med
, vol.11
, pp. 845-852
-
-
Jenkins, B.J.1
-
18
-
-
3042726888
-
STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells
-
Kanda, N. et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 23, 4921-4929 (2004).
-
(2004)
Oncogene
, vol.23
, pp. 4921-4929
-
-
Kanda, N.1
-
19
-
-
0036233585
-
Cytokine signaling in 2002: New surprises in the Jak/Stat pathway
-
O'Shea, J. J., Gadina, M., Schreiber, R. D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109 Suppl, S121-131 (2002).
-
(2002)
Cell
, vol.109
, pp. S121-131
-
-
O'Shea, J.J.1
Gadina, M.2
Schreiber, R.D.3
-
20
-
-
35348979761
-
Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression
-
Jackson, C. B. et al. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. J Pathol 213, 140-151 (2007).
-
(2007)
J Pathol
, vol.213
, pp. 140-151
-
-
Jackson, C.B.1
-
21
-
-
80053144962
-
A decade of exploring the cancer epigenome-biological and translational implications
-
Baylin, S. B., Jones, P. A. A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer 11, 726-734 (2011).
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 726-734
-
-
Baylin, S.B.1
Jones, P.A.2
-
22
-
-
77958065274
-
TGF-beta: Friend or foe? the role of TGF-beta/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy
-
Chou, J. L., Chen, L. Y., Lai, H. C., Chan, M. W. TGF-beta: friend or foe? The role of TGF-beta/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy. Expert Opin Ther Targets 14, 1213-1223 (2010).
-
(2010)
Expert Opin Ther Targets
, vol.14
, pp. 1213-1223
-
-
Chou, J.L.1
Chen, L.Y.2
Lai, H.C.3
Chan, M.W.4
-
23
-
-
84871296892
-
Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis
-
e129
-
Cheng, A. S. et al. Helicobacter pylori Causes Epigenetic Dysregulation of FOXD3 to Promote Gastric Carcinogenesis. Gastroenterology 144, 122-133 e129 (2013).
-
(2013)
Gastroenterology
, vol.144
, pp. 122-133
-
-
Cheng, A.S.1
-
24
-
-
6944250441
-
Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line
-
To, K. F. et al. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. Br J Cancer 91, 1335-1341 (2004).
-
(2004)
Br J Cancer
, vol.91
, pp. 1335-1341
-
-
To, K.F.1
-
25
-
-
85006234654
-
Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development
-
Yang, W. et al. Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development. Oncogene (2015).
-
(2015)
Oncogene
-
-
Yang, W.1
-
26
-
-
85008513848
-
Epigenetic inactivation of FAT4 contributes to gastric field cancerization
-
Yoshida, S. et al. Epigenetic inactivation of FAT4 contributes to gastric field cancerization. Gastric Cancer (2016).
-
(2016)
Gastric Cancer
-
-
Yoshida, S.1
-
27
-
-
0035870248
-
A gene hypermethylation profile of human cancer
-
Esteller, M., Corn, P. G., Baylin, S. B., Herman, J. G. A gene hypermethylation profile of human cancer. Cancer Res 61, 3225-3229 (2001).
-
(2001)
Cancer Res
, vol.61
, pp. 3225-3229
-
-
Esteller, M.1
Corn, P.G.2
Baylin, S.B.3
Herman, J.G.4
-
28
-
-
0035476236
-
Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma
-
Byun, D. S., Lee, M. G., Chae, K. S., Ryu, B. G., Chi, S. G. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res 61, 7034-7038 (2001).
-
(2001)
Cancer Res
, vol.61
, pp. 7034-7038
-
-
Byun, D.S.1
Lee, M.G.2
Chae, K.S.3
Ryu, B.G.4
Chi, S.G.5
-
29
-
-
79958741371
-
Aberrant TGFbeta/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer
-
Yeh, K. T. et al. Aberrant TGFbeta/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer. Epigenetics 6, 727-739 (2011).
-
(2011)
Epigenetics
, vol.6
, pp. 727-739
-
-
Yeh, K.T.1
-
30
-
-
0033529704
-
Stat3 as an oncogene
-
Bromberg, J. F. et al. Stat3 as an oncogene. Cell 98, 295-303 (1999).
-
(1999)
Cell
, vol.98
, pp. 295-303
-
-
Bromberg, J.F.1
-
31
-
-
43049183421
-
HER2-dependent MMP-7 expression is mediated by activated STAT3
-
Yuan, G. et al. HER2-dependent MMP-7 expression is mediated by activated STAT3. Cell Signal 20, 1284-1291 (2008).
-
(2008)
Cell Signal
, vol.20
, pp. 1284-1291
-
-
Yuan, G.1
-
32
-
-
84867046550
-
XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancreatic cancer cells
-
Liu, A. et al. XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancreatic cancer cells. PloS one 7, e46624 (2012).
-
(2012)
PloS One
, vol.7
, pp. 46624
-
-
Liu, A.1
-
33
-
-
60749119301
-
Role of STAT3 as a negative regulator in Mac2-binding protein expression
-
Park, Y. P. et al. Role of STAT3 as a negative regulator in Mac2-binding protein expression. The Korean journal of laboratory medicine 28, 230-238 (2008).
-
(2008)
The Korean Journal of Laboratory Medicine
, vol.28
, pp. 230-238
-
-
Park, Y.P.1
-
34
-
-
50849154478
-
Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer
-
Chan, M. W. et al. Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer. Neoplasia 10, 908-919 (2008).
-
(2008)
Neoplasia
, vol.10
, pp. 908-919
-
-
Chan, M.W.1
-
35
-
-
34250019385
-
Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia
-
Mullican, S. E. et al. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat Med 13, 730-735 (2007).
-
(2007)
Nat Med
, vol.13
, pp. 730-735
-
-
Mullican, S.E.1
-
36
-
-
59149084538
-
The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores
-
Irizarry, R. A. et al. The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nature genetics 41, 178-186 (2009).
-
(2009)
Nature Genetics
, vol.41
, pp. 178-186
-
-
Irizarry, R.A.1
-
37
-
-
0015298215
-
The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid
-
Penn, N. W., Suwalski, R., O'Riley, C., Bojanowski, K., Yura, R. The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. The Biochemical journal 126, 781-790 (1972).
-
(1972)
The Biochemical Journal
, vol.126
, pp. 781-790
-
-
Penn, N.W.1
Suwalski, R.2
O'Riley, C.3
Bojanowski, K.4
Yura, R.5
-
38
-
-
84908548564
-
Detection of DNA methylation by MeDIP and MBDCap assays: An overview of techniques
-
Hsu, H. K., Weng, Y. I., Hsu, P. Y., Huang, T. H., Huang, Y. W. Detection of DNA methylation by MeDIP and MBDCap assays: an overview of techniques. Methods Mol Biol 1105, 61-70 (2014).
-
(2014)
Methods Mol Biol
, vol.1105
, pp. 61-70
-
-
Hsu, H.K.1
Weng, Y.I.2
Hsu, P.Y.3
Huang, T.H.4
Huang, Y.W.5
-
39
-
-
0034736521
-
Retroviruses in foreign species and the problem of provirus silencing
-
Svoboda, J., Hejnar, J., Geryk, J., Elleder, D., Vernerova, Z. Retroviruses in foreign species and the problem of provirus silencing. Gene 261, 181-188 (2000).
-
(2000)
Gene
, vol.261
, pp. 181-188
-
-
Svoboda, J.1
Hejnar, J.2
Geryk, J.3
Elleder, D.4
Vernerova, Z.5
-
40
-
-
25844465921
-
Epigenetic therapy of cancer with 5-aza-2?-deoxycytidine (decitabine)
-
Momparler, R. L. Epigenetic therapy of cancer with 5-aza-2?-deoxycytidine (decitabine). Semin Oncol 32, 443-451 (2005).
-
(2005)
Semin Oncol
, vol.32
, pp. 443-451
-
-
Momparler, R.L.1
-
41
-
-
2642531973
-
Epigenetics in human disease and prospects for epigenetic therapy
-
Egger, G., Liang, G., Aparicio, A., Jones, P. A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463 (2004).
-
(2004)
Nature
, vol.429
, pp. 457-463
-
-
Egger, G.1
Liang, G.2
Aparicio, A.3
Jones, P.A.4
-
42
-
-
84928169526
-
Helicobacter pylori-induced STAT3 activation and signalling network in gastric cancer
-
Zhao, J. et al. Helicobacter pylori-induced STAT3 activation and signalling network in gastric cancer. Oncoscience 1, 468-475 (2014).
-
(2014)
Oncoscience
, vol.1
, pp. 468-475
-
-
Zhao, J.1
-
43
-
-
0038527642
-
Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor
-
Di Croce, L. et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295, 1079-1082 (2002).
-
(2002)
Science
, vol.295
, pp. 1079-1082
-
-
Di Croce, L.1
-
44
-
-
18744395503
-
STAT3-and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes.
-
Zhang, Q. et al. STAT3-and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci USA 102, 6948-6953 (2005).
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 6948-6953
-
-
Zhang, Q.1
-
45
-
-
33645530423
-
Physical and functional interactions between Daxx and STAT3
-
Muromoto, R. et al. Physical and functional interactions between Daxx and STAT3. Oncogene 25, 2131-2136 (2006).
-
(2006)
Oncogene
, vol.25
, pp. 2131-2136
-
-
Muromoto, R.1
-
46
-
-
77957329141
-
Minireview: Nuclear hormone receptor 4A signaling: Implications for metabolic disease
-
Pearen, M. A., Muscat, G. E. Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol Endocrinol 24, 1891-1903 (2010).
-
(2010)
Mol Endocrinol
, vol.24
, pp. 1891-1903
-
-
Pearen, M.A.1
Muscat, G.E.2
-
47
-
-
84954052324
-
Nuclear receptor 4A (NR4A) family-orphans no more
-
Safe, S. et al. Nuclear receptor 4A (NR4A) family-orphans no more. J Steroid Biochem Mol Biol 157, 48-60 (2016).
-
(2016)
J Steroid Biochem Mol Biol
, vol.157
, pp. 48-60
-
-
Safe, S.1
-
48
-
-
44249088564
-
The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle
-
Pearen, M. A. et al. The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. Endocrinology 149, 2853-2865 (2008).
-
(2008)
Endocrinology
, vol.149
, pp. 2853-2865
-
-
Pearen, M.A.1
-
49
-
-
84918768679
-
The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer
-
Beard, J. A., Tenga, A., Chen, T. The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer. Cell Signal 27, 257-266 (2015).
-
(2015)
Cell Signal
, vol.27
, pp. 257-266
-
-
Beard, J.A.1
Tenga, A.2
Chen, T.3
-
50
-
-
84355161519
-
Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells
-
Huang, S. et al. Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells. Cancer letters 315, 198-205 (2012).
-
(2012)
Cancer Letters
, vol.315
, pp. 198-205
-
-
Huang, S.1
-
52
-
-
84878432714
-
OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
-
Kim, M. J. et al. OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells. Cancer letters 335, 145-152 (2013).
-
(2013)
Cancer Letters
, vol.335
, pp. 145-152
-
-
Kim, M.J.1
-
53
-
-
77649092118
-
Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer
-
Chou, J. L. et al. Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Lab Invest 90, 414-425 (2010).
-
(2010)
Lab Invest
, vol.90
, pp. 414-425
-
-
Chou, J.L.1
-
54
-
-
84945162360
-
Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential noninvasive biomarker for the detection of urothelial carcinoma
-
Yeh, C. M. et al. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential noninvasive biomarker for the detection of urothelial carcinoma. Oncotarget 6, 29555-29572 (2015).
-
(2015)
Oncotarget
, vol.6
, pp. 29555-29572
-
-
Yeh, C.M.1
|